| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CLINICAL CASE SEMINAR |
Department of Pediatrics (C.A.K., D.R.B.), Instituto da Criança, University of Sao Paulo, 05403-900 Sao Paulo, Brazil; Commissariat à lEnergie Atomique (M.D., M.L.), Institut de Génomique, Centre National de Génotypage, 91057 Evry, France; Unité Mixte de Recherche (UMR)_S893 (E.Bo., H.E.M., M.M., M.N., J.C., J.M.), Institut National de la Santé et de la Recherche Médicale (INSERM), Université Pierre et Marie Curie (UPMC) Univ Paris 06, Centre de Recherche (CDR) Saint-Antoine, F-75012 Paris, France; UMR_S872 (S.L.L., I.D.), INSERM, UPMC Univ Paris 06, CDR des Cordeliers, F-75006 Paris, France; Service dImagerie Médicale (E.Br.), Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France; Department of Radiology (C.C.L.), School of Medicine, University of Sao Paulo, 05403-001 Sao Paulo, Brazil; and Department of Clinical Biochemistry (R.K.S., S.O.), University of Cambridge, Addenbrookes Hospital, Cambridge CB2 2QR, United Kingdom
Address all correspondence and requests for reprints to: Jocelyne Magré, INSERM UMR_S893, Faculté de Médecine Pierre et Marie Curie, Site Saint-Antoine, 27 rue Chaligny, 75012 Paris, France. E-mail: Jocelyne.Magre{at}st-antoine.inserm.fr.
Context: Berardinelli-Seip congenital lipodystrophy (BSCL) is a rare recessive disease characterized by near absence of adipose tissue, resulting in severe dyslipidemia and insulin resistance. In most reported cases, BSCL is due to alterations in either seipin, of unknown function, or 1-acylglycerol-3-phosphate acyltransferase-β (AGPAT2), which catalyzes the formation of phosphatidic acid.
Objective: We sought to determine the genetic origin of the unexplained cases of BSCL. We thus sequenced CAV1, encoding caveolin-1, as a candidate gene involved in insulin signaling and lipid homeostasis. CAV1 is a key structural component of plasma membrane caveolae, and Cav1-deficient mice display progressive loss of adipose tissue and insulin resistance.
Design: We undertook phenotyping studies and molecular screening of CAV1 in four patients with BSCL with no mutation in the genes encoding either seipin or AGPAT2.
Results: A homozygous nonsense mutation (p.Glu38X) was identified in CAV1 in a patient with BSCL born from a consanguineous union. This mutation affects both the
- and β-CAV1 isoforms and ablates CAV1 expression in skin fibroblasts. Detailed magnetic resonance imaging of the proband confirmed near total absence of both sc and visceral adipose tissue, with only vestigial amounts in the dorsal sc regions. In keeping with the lack of adipose tissue, the proband was also severely insulin resistant and dyslipidemic. In addition, the proband had mild hypocalcemia likely due to vitamin D resistance.
Conclusions: These findings identify CAV1 as a new BSCL-related gene and support a critical role for caveolins in human adipocyte function.
This article has been cited by other articles:
![]() |
A. Garg and A. K. Agarwal Caveolin-1: A New Locus for Human Lipodystrophy J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1183 - 1185. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |